Thursday, 11 September 2014

08:00

Registration

09:30

Welcome Address


Session 1- Profiling Drug Metabolites

09:40

Metabolite Profiling and Structure Elucidation in Drug Discovery/ Development
Girish Gudi, Vice President, Glenmark Pharmaceuticals, India

10:20

Biomimiks™ as Chemosynthetic Livers: Predict, Prepare and Prove the Structure, Activity and Toxicity of Drug Metabolites
Mukund Chorghade, President & CSO, Chorghade Enterprises, United States of America

11:00

Coffee Break and Networking in Exhibition Area


Session 2: Strategies and Approaches to improve ADMET Properties

11:20

Optimizing ADMET: From Hit to Lead and Lead to Candidate Selection
Anagha Damre, Senior Group Leader/Head, Piramal Healthcare Ltd, India

12:00

Computational Techniques in Lead Generation, Optimization & ADMET Prediction
Vellarkad Viswanadhan, Vice President and Partner, Signalchem Lifescience Corporation, India

12:40

Microsampling and Dried Blood Spot Analysis: Better Alternatives and Improved Ethics for Use of Animals in ADMET Studies
Deepak Barot, President & CEO, PBR Private Limited, India

13:20

Lunch and Networking in the Exhibition Area


Session 3: Approaches in ADR Evaluation

14:20

Albert LiKeynote Presentation

Application of Human Hepatocytes in the Evaluation of Human-Specific Adverse Drug Properties in Drug Development
Albert Li, President and CEO, In Vitro ADMET Laboratories LLC, United States of America

15:20

Metabonomics: A Novel Platform for Testing Teratogenic Potential of Drugs
Neeraj Sinha, Senior Principal Scientist and Head, CSIR Central Drug Research Institute, India

15:50

Coffee Break and Networking in Exhibition Area


SPECIAL LECTURE ON EXTRAHEPATIC DRUG METABOLISM

16:10

Saranjit SinghKeynote Presentation

Extrahepatic Drug Metabolism
Saranjit Singh, Professor/Head, NIPER Mohali, India

17:10

End of the Conference